论文部分内容阅读
为探讨替米沙坦联合苯磺酸左旋氨氯地平治疗肾移植术后高血压的疗效。本研究采用随机、双盲、平行对照法将120例肾移植术后高血压随机分为观察组和对照组,观察治疗前及治疗后测定各组的血压变化。现报告如下。1资料与方法1.1临床资料:选取我院2011年8月至2013年8月收治的120例肾移植术后高血压患者作为本次研究的对象。所有患者均经过相关的体格检查和实验室检查确诊为肾移植术后高血压,收缩压(SBP)在140~180 mmHg(1 mmHg=0.133kPa),舒张压(DBP)在90~110mmHg,其中男性
To investigate the effect of telmisartan combined with levamlodipine besylate in the treatment of hypertension after renal transplantation. In this study, 120 cases of post-transplant hypertension were randomly divided into observation group and control group using randomized, double-blind and parallel-controlled method. The changes of blood pressure in each group before and after treatment were observed. The report is as follows. 1 Materials and Methods 1.1 Clinical data: Select our hospital from August 2011 to August 2013 admitted 120 cases of post-renal hypertension patients as the object of this study. All patients were diagnosed as having hypertension after renal transplantation by physical examination and laboratory examination. The systolic blood pressure (SBP) ranged from 140 to 180 mmHg (1 mmHg = 0.133 kPa) and diastolic blood pressure (DBP) ranged from 90 to 110 mmHg male